Evaluation of treatment of actinic keratosis with hydrogen peroxide
Phase 2
- Conditions
- actinic keratosis.
- Registration Number
- IRCT20190928044912N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Patients who are at least 18 years old with at least 4 actinic keratosis on the skin areas that are sun exposed
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of recovery. Timepoint: day 21 - day 42 - day 63 - day 96. Method of measurement: Examines the dermographic and dermoscopic photos taken with the FotoFinder device.;Complications. Timepoint: day 21 - day 42 - day 63 - day 96. Method of measurement: Examines the dermographic and dermoscopic photos taken with the FotoFinder device.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie 35% hydrogen peroxide's efficacy in actinic keratosis keratinocyte apoptosis?
What are the primary clinical endpoints in IRCT20190928044912N1 Phase II trial comparing hydrogen peroxide to cryotherapy?
Which biomarkers predict response to 35% hydrogen peroxide in actinic keratosis subtypes with UV-induced DNA damage?
What are the potential adverse events of 35% hydrogen peroxide treatment for actinic keratosis compared to cryotherapy?
How do hydrogen peroxide-based therapies compare to 5-fluorouracil or imiquimod in actinic keratosis treatment outcomes?